Merrimack Pharmaceuticals, Inc.
Records under this name other than the patents Merrimack Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Back to Merrimack Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,329,213 | Liposomes Useful for Drug Delivery now held by Ipsen Biopharm Ltd. In force · High confidence | In force | High confidence | |
| US 7,846,440 | Antibodies Against ERBB3 and Uses Thereof now held by 14NER Oncology, Inc. In force · High confidence | In force | High confidence | |
| US 9,487,588 | Antibodies Against the Ectodomain of ERBB3 and Uses Thereof now held by 14NER Oncology, Inc. In force · Low confidence | In force | Low confidence | |
| US 8,147,867 | Liposomes Useful for Drug Delivery now held by Ipsen Biopharm Ltd. In force · High confidence | In force | High confidence | |
| US 8,691,225 | Antibodies Against the Ectodomain of ERBB3 and Uses Thereof now held by 14NER Oncology, Inc. In force · Medium confidence | In force | Medium confidence | |
| US 8,658,203 | Liposomes Useful for Drug Delivery to the Brain now held by Ipsen Biopharm Ltd. In force · High confidence | In force | High confidence | |
| US 8,961,966 | Antibodies Against ERBB3 and Uses Thereof now held by 14NER Oncology, Inc. In force · Low confidence | In force | Low confidence | |
| US 9,238,080 | Bi-specific fusion proteins now held by Silver Creek Pharmaceuticals, Inc. In force · Medium confidence | In force | Medium confidence | |
| US 9,718,892 | A method of treating myocardial infarction by administering a bi-specific fusion protein now held by Silver Creek Pharmaceuticals, Inc. In force · High confidence | In force | High confidence | |
| US 9,982,060 | Bi-Specific Fusion Proteins now held by Silver Creek Pharmaceuticals, Inc. In force · High confidence | In force | High confidence |